PHARMACY

Amneal gets FDA nod for generic Exelon patch
The FDA has approved Amneal's generic Exelon patch, which had a market value of roughly $225 million.
Teva, Amgen resolve generic Sensipar dispute
Teva has agreed to stop selling its generic Sensipar after settling recent litigation with Amgen.

Ferring Pharmaceuticals acquires generic ganirelix acetate injection rights

Ferring has acquired U.S. commercialization rights for generic ganirelix acetate injection from Sun Pharma.
FDA approves expanded use of Adacel vaccine

Adacel is now the first and only Tdap vaccine in the United States approved for a repeat dose in people between the ages of 10-to-64 years old, administered eight or more years after the first vaccination.
Camber launches generic Albenza

Camber is debuting a generic Albenza for the treatment of tapeworms and other parasites.
CVS Health launches $100 million building healthier communities initiative

On the heels of its acquisition of Aetna, CVS Health is committing $100 million to build healthier communities.
AllianceRx Walgreens Prime earns URAC reaccreditation

AllianceRx Walgreens Prime's URAC reaccreditation affirms its commitment to patient care, the company said.
Issues Summit Panelists talk hurdles to patient-facing care

During an executive panel at the Drug Store News Industry Issues Summit in New York City in late November, panelists focused on how to improve patient-facing care in community-based pharmacy.
6 trends driving pharmacy’s future

At the DSN Industry Issues Summit Chris Dimos, president of retail solutions at McKesson, outlined six key trends in the pharmacy space.
Webinar to focus on flu prevention in older adults

Sanofi Pasteur will be offering a live educational webcast for pharmacists aimed at helping pharmacists understand the impact the flu can have on older patients and those with chronic conditions.